1-3 of 3
David Gandara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma. A California Cancer Consortium Study.

Mark Kirschbaum, MD, Leslie Popplewell, Auayporn P. Nademanee, Vinod Pullarkat, Maria Delioukina, Jasmine M. Zain, Deron Matsuoka, Bernadette Pulone, Paul Frankel, Igor Espinoza-Delgado, MD, Stephen J. Forman, David Gandara, Edward Newman
Journal: Blood
Blood (2008) 112 (11): 1564.
https://doi.org/10.1182/blood.V112.11.1564.1564
Published: 2008
Journal Articles

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Relapsed or Refractory Indolent Non Hodgkin Lymphoma. A California Cancer Consortium Study.

Mark H. Kirschbaum, MD, Jasmine M. Zain, MD, Leslie Popplewell, MD, Vinod Pullarkat, MD, Auayporn P. Nademanee, MD, Maria L. Delioukina, MD, Bernadette Pulone, RN, Deron Matsuoka, BS, Paul Frankel, PhD, Zwiebel A. James, MD, Stephen J. Forman, MD, Edward Newman, PhD, David Gandara, MD
Journal: Blood
Blood (2007) 110 (11): 2568.
https://doi.org/10.1182/blood.V110.11.2568.2568
Published: 2007
Journal Articles

Phase II Randomized Trial of Bevacizumab Versus Bevacizumab and Thalidomide for Relapsed/Refractory Multiple Myeloma.

George Somlo, MD, William Bellamy, PhD, Todd M. Zimmerman, MD, Paul Frankel, PhD, Joe Tuscano, MD, Margaret O’Donnell, MD, Ann Mohrbacher, MD, Stephen Forman, MD, Helen Chen, MD, James Doroshow, MD, David Gandara, MD
Journal: Blood
Blood (2005) 106 (11): 2571.
https://doi.org/10.1182/blood.V106.11.2571.2571
Published: 2005